AmeriCann is honored in the Best For Workers list, which includes businesses that earned a Workers score in the top 10 percent of more than 2,400 Certified B Corporations on the B Impact Assessment. The assessment measures a company’s impact on its workers, community, customers and the environment. To certify as B Corporations, companies like AmeriCann must complete the full assessment and have their answers verified by B Lab.
AmeriCann was the first public cannabis company in the world to earn the prestigious B Corp certification when it did so in 2016.
“To be recognized as one of the best from a group of such exceptional companies is a real honor,” stated AmeriCann president Tim Keogh. “The cannabis business is projected by many to be the fastest growing in the world. One of our goals is to serve as a model for what is possible in this emerging industry by setting the highest standards for social and environmental performance, accountability, and transparency.”
The Workers section of the B Impact Assessment assesses the company’s relationship with its workforce. It measures the overall work environment within the company by assessing management/worker communication, job flexibility, corporate culture, training, compensation and worker health and safety practices. Honorees scoring in the top 10 percent set a gold standard for the high impact that business as a force for good can make on employees around the world.
AmeriCann is developing sustainable cultivation and processing facilities for the regulated cannabis industry. AmeriCann’s flagship project, the Massachusetts Medical Cannabis Center, located 47 miles south of Boston, MA, is a state-of-the-art greenhouse project that will consist of a number of planned phases for multiple tenants in the Massachusetts medical marijuana market.
1,000,000 square feet of medical cannabis cultivation and processing in Freetown, Massachusetts. The state-of-the-art, sustainable, greenhouse project will consist of multiple planned phases for tenants in the Massachusetts medical marijuana market. Voters in Massachusetts approved legalizing the adult use of recreational marijuana in November of 2016. The state is on track to open the first cannabis storefronts for Adult-Use by July 1, 2018, making Massachusetts the first state in the Northeast to legalize adult-use cannabis.’ data-reactid=”39″>The Massachusetts Medical Cannabis Center is approved for nearly 1,000,000 square feet of medical cannabis cultivation and processing in Freetown, Massachusetts. The state-of-the-art, sustainable, greenhouse project will consist of multiple planned phases for tenants in the Massachusetts medical marijuana market. Voters in Massachusetts approved legalizing the adult use of recreational marijuana in November of 2016. The state is on track to open the first cannabis storefronts for Adult-Use by July 1, 2018, making Massachusetts the first state in the Northeast to legalize adult-use cannabis.
AmeriCann’s Cannopy System uniquely combines expertise from traditional horticulture, lean manufacturing, regulatory compliance and cannabis cultivation to create superior facilities and procedures. The company is planning to replicate the Cannopy platform in additional states.
The first phase of the MMCC project consists of 30,000 sq. ft. of cultivation, processing and research facility.
AmeriCann has developed and owns “Solanna”, a new comprehensive line of nutraceutical-grade cannabis infused products. AmeriCann has created the brand, packaging concepts and invested significantly in Standard Operating Procedures and Good Manufacturing Practices to ensure safety, consistency and efficacy across the product offering.
The intellectual property for Solanna will be licensed by AmeriCann to regulated cannabis businesses and will initially focus on providing healthier alternatives to smoking that include:
- Topical lotions and balms
- Sublingual tinctures
- Oral dissolving film
- Trans-dermal applications
The Company plans to expand the product line to include edible products, health drinks, and branded concentrates. The products are designed to allow consumers to manage dosage through micro-dosing and to improve efficacy by incorporating blends of other plants, essential oils and other supplements that enhance and compliment the benefits of cannabis.
The Solanna line of products will be offered exclusively through AmeriCann’s Preferred Partners.
www.sec.gov.” data-reactid=”92″>This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional uncertainties that could impact the Company’s forward-looking statements, please see the Company’s Registration Statement on Form S-1, which the Company recently filed with the SEC and which may be viewed at www.sec.gov.Hayden IR
The post AmeriCann Honored As Best For Workers, Creating Most Positive Impact For Employees appeared first on Cannabis Stock Picks.
Go to OG News Source